Skip to content

Health Checks in vulnerable groups: the role of beliefs and expectations.

Health Checks in vulnerable groups: the role of beliefs and expectations. - CHECK'D Cultural Health check Evaluating Cardiometabolic & Kidney Disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35982
Enrollment
1700
Registered
2011-10-17
Start date
2012-06-11
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hoog risico op cardiometabole aandoeningen en nierschade. Cardiovascular disease diabetes kidney failure.

Interventions

Invitation strategies: Currently, the HRA is provided by mail or online. In this study, the effect of three invitation strategies will be tested: 1. The usual strategy: all patients will receive an in

Sponsors

LekkerLangLeven. Diabetes Fonds, T.a.v. Afdeling Wetenschappelijk Onderzoek en Preventie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Turkish, Moroccan or Creole Surinamese origin and 45 - 70 years old. Hindustani Surinamese origin and 35 - 70 years old. Native Dutch origin with a low socioeconomic status and 45 - 70 years old.

Exclusion criteria

Exclusion criteria: Diagnosed cardiometabolic or kidney disease.

Design outcomes

Primary

MeasureTime frame
1. Participation in HRA (part 1 of PreventieConsult) and participation in consultations at GP (part 2 of PreventieConsult). 2. (Practical and psychological) determinants of participation in HRA and (practical and psychological) determinants of participation in consultations at GP.

Secondary

MeasureTime frame
1. Test results HRA (no increased risk - slightly increased risk - increased risk). 2. Final risk profile after consultations at GP (no increased risk - slightly increased risk - increased risk) and newly diagnosed conditions.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)